Literature DB >> 23326159

Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Halina Cichoż-Lach1, Agata Michalak.   

Abstract

Hepatic encephalopathy is a medical phenomenon that is described as a neuropsychiatric manifestation of chronic or acute liver disease that is characterized by psychomotor, intellectual and cognitive abnormalities with emotional/affective and behavioral disturbances. This article focuses on the underlying mechanisms of the condition and the differences between hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. Hepatic encephalopathy is a serious condition that can cause neurological death with brain edema and intracranial hypertension. It is assumed that approximately 60%-80% of patients with liver cirrhosis develop hepatic encephalopathy. This review explores the complex mechanisms that lead to hepatic encephalopathy. However, noncirrhotic hyperammonemic encephalopathy is not associated with hepatic diseases and has a completely different etiology. Noncirrhotic hyperammonemic encephalopathy is a severe occurrence that is connected with multiple pathogeneses.

Entities:  

Keywords:  Ammonia; Astrocyte; Hepatic encephalopathy; Noncirrhotic hyperammonemic encephalopathy; Oxidative stress; Pathogeneses

Mesh:

Substances:

Year:  2013        PMID: 23326159      PMCID: PMC3545226          DOI: 10.3748/wjg.v19.i1.26

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  85 in total

1.  Fulminant liver failure models with subsequent encephalopathy in the mouse.

Authors:  Ann-Marie T Baine; Tomohide Hori; Feng Chen; Lindsay B Gardner; Shinji Uemoto; Justin H Nguyen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-12

Review 2.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.

Authors:  A S Basile; E A Jones
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

4.  Mitochondrial dysfunction as a mediator of hippocampal apoptosis in a model of hepatic encephalopathy.

Authors:  J Bustamante; S Lores-Arnaiz; S Tallis; D M Roselló; N Lago; A Lemberg; A Boveris; J C Perazzo
Journal:  Mol Cell Biochem       Date:  2011-04-20       Impact factor: 3.396

5.  Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.

Authors:  Manuel Romero-Gómez; María Jover; José A Del Campo; José L Royo; Elena Hoyas; José J Galán; Carmina Montoliu; Eugenia Baccaro; Mónica Guevara; Juan Córdoba; Germán Soriano; José M Navarro; Carmen Martínez-Sierra; Lourdes Grande; Antonio Galindo; Emilia Mira; Santos Mañes; Agustín Ruiz
Journal:  Ann Intern Med       Date:  2010-09-07       Impact factor: 25.391

6.  Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.

Authors:  Rajiv Jalan; Steven W M Olde Damink; Peter C Hayes; Nicolaas E P Deutz; Alistair Lee
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

Review 7.  Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.

Authors:  Debbie L Shawcross; Shabnam S Shabbir; Nicholas J Taylor; Robin D Hughes
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

8.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

9.  Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-04       Impact factor: 6.200

10.  Management of hepatic encephalopathy.

Authors:  G Wright; A Chattree; R Jalan
Journal:  Int J Hepatol       Date:  2011-09-21
View more
  24 in total

Review 1.  Cause for Confusion: Noncirrhotic Hyperammonemic Encephalopathy.

Authors:  Avash Kalra; J P Norvell
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

Review 2.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

3.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

4.  Nitrogenous compounds in the saliva and blood of cirrhotic patients: a cross-sectional study.

Authors:  Nathália Tuany Duarte; Jefferson R Tenório; Natália Silva Andrade; Fabiana Martins; Marina Gallottini; Karem L Ortega
Journal:  Clin Oral Investig       Date:  2022-02-28       Impact factor: 3.573

5.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

6.  Carbon Tetrachloride Increases the Pro-inflammatory Cytokines Levels in Different Brain Areas of Wistar Rats: The Protective Effect of Acai Frozen Pulp.

Authors:  Fernanda de Souza Machado; Jéssica Pereira Marinho; Ana Lúcia Abujamra; Caroline Dani; André Quincozes-Santos; Cláudia Funchal
Journal:  Neurochem Res       Date:  2015-08-18       Impact factor: 3.996

Review 7.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

8.  Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.

Authors:  Massimiliano Allegritti; Benedetta Enrico; Emanuela Basile; Lara de Vito; Antonino Morabito; Roberto Cirocchi; Michela Giustozzi; Giovanni Passalacqua
Journal:  Dig Dis Sci       Date:  2020-04       Impact factor: 3.199

9.  Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.

Authors:  Ruby Upadhyay; Thomas P Bleck; Katharina M Busl
Journal:  Case Rep Med       Date:  2016-09-21

10.  Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.

Authors:  Jia Zhu; Xingshun Qi; Haonan Yu; Eric M Yoshida; Nahum Mendez-Sanchez; Xintong Zhang; Ran Wang; Han Deng; Jing Li; Dan Han; Xiaozhong Guo
Journal:  United European Gastroenterol J       Date:  2018-04-23       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.